(Q28241221)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14748749%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

review article

1 reference

title

Invited review: the evolution of antidepressant mechanisms (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14748749%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14748749%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Alan L. Hudson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14748749%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

author name string

D J Nutt

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14748749%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

language of work or name

English

0 references

publication date

1 February 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14748749%20AND%20SRC:MED&resulttype=core&format=json

Fundamental and Clinical Pharmacology

17 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14748749%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14748749%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14748749%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

page(s)

1-21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14748749%20AND%20SRC:MED&resulttype=core&format=json

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

17 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.2004.00195.X

Increased adenylyl cyclase type 1 mRNA, but not adenylyl cyclase type 2 in the rat hippocampus following antidepressant treatment

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.2004.00195.X

Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine

21 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1472-8206.2004.00195.X

Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Cross-national epidemiology of major depression and bipolar disorder

21 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

The catecholamine hypothesis of affective disorders: a review of supporting evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Mode of action of antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Antidepressants: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Functional evidence for subsensitivity of noradrenergic α2 receptors after chronic desipramine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Presynaptic adrenergic receptor sensitivity in depression. The effect of long-term desipramine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Interaction of the antidepressant mirtazapine with alpha2-adrenoceptors modulating the release of 5-HT in different rat brain regions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Parachlorophenylalanine Reversal of Tranylcypromine Effects in Depressed Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

How does pindolol improve antidepressant action?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Effectiveness of ipsapirone, a 5-HT-1A partial agonist, in major depressive disorder: support for the role of 5-HT-1A receptors in the mechanism of action of serotonergic antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Interactions of trazodone with serotonin neurons and receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Effect of chronic tryptophan depletion on the circadian rhythm of wheel-running activity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Tryptophan depletion during continuous CSF sampling in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

The effect of acute tryptophan depletion and fenfluramine on quantitative EEG and mood in healthy male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Neurobiology of tryptophan depletion in depression: effects of m-chlorophenylpiperazine (mCPP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

The neurobiology of tryptophan depletion in depression: effects of intravenous tryptophan infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Positron emission tomography measurement of cerebral metabolic correlates of tryptophan depletion-induced depressive relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

The role of dopamine in the mechanism of action of antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Effect of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

The effect of imipramine on the amount of mRNA coding for rat dopamine D2 autoreceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

The behavioural effects of pramipexole, a novel dopamine receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Pramipexole for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Adrenal gland volume in major depression: relationship to basal and stimulated pituitary-adrenal cortical axis function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Adrenal gland volume in major depression. Increase during the depressive episode and decrease with successful treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

The clinical use of the dexamethasone suppression test in DSM-III affective disorders: correlation with the severe depressive subtypes of melancholia and psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Hypercortisolemia and hippocampal changes in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Blunting of ACTH response to human CRH in depressed patients is avoided by metyrapone pretreatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Antidepressants and hypothalamic-pituitary-adrenocortical regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Persistent changes in corticotropin-releasing factor neuronal systems induced by maternal deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Cerebrospinal fluid neuropeptides in mood disorder and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Antiglucocorticoid treatment of refractory depression with ketoconazole: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Metyrapone displays antidepressant-like properties in preclinical paradigms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

The olfactory bulbectomized rat as a model of depression: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Interferon alpha (IFNalpha) and psychiatric syndromes: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Depression, stress and immunological activation: the role of cytokines in depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Indicators of immune activation in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

TNF alpha mimics the endocrine but not the thermoregulatory responses of bacterial lipopolysaccharide (LPS): correlation with FOS-expression in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Synergistic effects of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha: central monoamine, corticosterone, and behavioral variations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Regulation of the human serotonin transporter by interleukin-1 beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Neurokinin(1) receptor antagonists as potential antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

First dual NK(1) antagonists-serotonin reuptake inhibitors: synthesis and SAR of a new class of potential antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Is CREB a key to neuronal survival?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Volumetric reduction in left subgenual prefrontal cortex in early onset depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

G Protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Cyclic AMP-mediated signaling components are upregulated in the prefrontal cortex of depressed suicide victims

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Antidepressant-like effect of brain-derived neurotrophic factor (BDNF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Decreased serum brain-derived neurotrophic factor levels in major depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Immobilization stress reduced the expression of neurotrophins and their receptors in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Antidepressants for the new millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Functional antagonists at the NMDA receptor complex exhibit antidepressant actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Antidepressant activity of non-competitive and competitive NMDA receptor antagonists in a chronic mild stress model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

The N-methyl-D-aspartate receptor, synaptic plasticity, and depressive disorder. A critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Tolerance to anxiolytic- and antidepressant-like effects of a partial agonist of glycineB receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Antidepressant effects of ketamine in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

GABA function in mood disorders: an update and critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Neurosteroids: a novel function of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Neurosteroids and GABAA receptor function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Neuroactive steroids: mechanisms of action and neuropsychopharmacological perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Buprenorphine treatment of refractory depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Effects of fluoxetine administration on mu-opoid receptor immunostaining in the rat forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

The effect of naloxone on adrenocorticotropin and cortisol release: evidence for a reduced response in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

CCK-B receptors in the limbic system modulate the antidepressant-like effects induced by endogenous enkephalins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Effects of histamine H3 receptor ligands in experimental models of anxiety and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 2. Chronic treatment results in downregulation of cortical beta-adrenoceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

'Seeing through a glass darkly': casting light on imidazoline 'I' sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Localization of I2-imidazoline binding sites on monoamine oxidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Major depression following smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Cigarette smoking: implications for psychiatric illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Major depression and stages of smoking. A longitudinal investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Symptoms of tobacco withdrawal. A replication and extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Effects of systemic nicotine on serotonin release in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Acute and long-term changes in the mesolimbic dopamine pathway after systemic or local single nicotine injections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Antidepressantlike effects of chronic nicotine on learned helplessness paradigm in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Effect of caffeine and nicotine on avoidance learning in mice: lack of interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Antidepressant effects of nicotine in an animal model of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

The scientific, quasi-scientific and popular literature on the use of St. John's Wort in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Hypericum perforatum extracts as potential antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Effects of Hypericum perforatum on levels of 5-hydroxytryptamine, noradrenaline and dopamine in the cortex, diencephalon and brainstem of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Hyperforin as a possible antidepressant component of hypericum extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Hyperforin enhances the extracellular concentrations of catecholamines, serotonin and glutamate in the rat locus coeruleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

St John's wort for depression--an overview and meta-analysis of randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2004.00195.X

10.1111/J.1472-8206.2004.00195.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14748749%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

1 reference